Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03965845 |
Title | A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Calithera Biosciences, Inc |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA Hematology/Oncology | Santa Monica | California | 90095 | United States | Details | |
Emory, Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | United States | Details | |
Rush University Medical Center | Chicago | Illinois | 60612 | United States | Details | |
University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | United States | Details | |
Regions Cancer care Center | Saint Paul | Minnesota | 55101 | United States | Details | |
Sarah Cannon Research Institute- Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
MD Anderson | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research Therapeutic, LLC | San Antonio | Texas | 78229 | United States | Details | |
University of Wisconsin Clinical Science Center | Madison | Wisconsin | 53792 | United States | Details |